Searched for
GLAXOSMITHKLINE CONSUMER HEALTHCARE INDIA
Falling crude, stronger rupee could boost earnings outlook for India: Deepak ShenoyIndian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...- Ayushman Bharat card: Eligibility, benefits, how to apply online and documents required for PMJAYThe Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) is expanding healthcare access, with 6 crore senior citizens enrolled and o...
- ET Most Innovative AI Product Awards 2026: Recognising the AI innovations driving business transformationAs artificial intelligence becomes central to how organisations operate, compete, and grow, businesses are increasingly looking for solutio...
- Delhi man's new 3-ton AC fails to cool; consumer court orders full refund plus Rs 25,000 compensationA Delhi consumer court has ordered Fujitsu General India to refund Rs 1.14 lakh to a customer whose 3-ton split AC failed to provide adequa...
- No Covid, yet Rs 3.71 lakh hospital bill: Gujarat man's insurance paid only Rs 1.78 lakh, deducting Rs 1.64 lakh; Then court delivered justiceA Gujarat consumer commission ordered a hospital and doctor to refund Rs 1.64 lakh to a patient. The patient was wrongly billed under a Cov...
- “Innovation is in India’s DNA,” says PM Modi at Bharat Innovates event in FranceSpeaking at Bharat Innovates 2026 in France, PM Narendra Modi declared India is now a major global innovation center, actively contributing...
- 12 years of Modi government strengthened India's health sector through accessibility and digital innovation: Amit ShahIndia's health sector has seen historic changes in the last 12 years. Accessible, affordable, and quality healthcare is now a reality for c...
- India known as nation with world's largest healthcare programme: PM ModiPrime Minister Narendra Modi said India has made healthcare more affordable and accessible over the past 12 years through initiatives such ...
- Maharashtra FDA bars hospitals from forcing patients to buy medicines in-houseMaharashtra's Food and Drug Administration has issued a significant directive. Hospitals and medical practitioners must now allow patients ...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- PL Capital cuts Nifty target to 26,449, lists 16 high conviction stock picksAmidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...
- 'Not a great environment for Indian market': Harsha Upadhyaya on Iran-US tensions, IT outlook, pharma bet, and where to be cautiousGlobal challenges are impacting Indian stocks. West Asian tensions and rising US inflation create headwinds. Tech sector shifts also affect...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Carlyle seeks banks for India IPO of healthcare RCM providerCarlyle has sought investment bank pitches for a potential India IPO of its healthcare revenue cycle management platform created through th...
- Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...
- Haleon to invest Rs 2,000 crore to set up first India plantHaleon is investing Rs 2,000 crore to build its first manufacturing plant in Pithampur, India. This move sharpens its focus on India, a fas...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
- GSK's Calpol a well-known trademark: High CourtThe Delhi High Court has recognized GlaxoSmithKline Pharmaceuticals' pain and fever medicine, Calpol, as a well-known trademark. This desig...
Load More
